(Source: ECI/ABP News/ABP Majha)
PM Modi To Share CoWin's Success In Global Conclave And Discuss 'Tech Backbone' Of Covid Inoculation
"The Conclave aims to share India's experience with regards to Universal Vaccination to fight Covid-19 through Co-WIN platform," as per the NHA website.
New Delhi: Prime Minister Narendra Modi will address, Co-WIN Global Conclave on Monday, where the country will share the CoWIN's success story with various countries that have shown interest in learning about it.
The meeting will be held virtually at 3 PM today and will see participation from health and technology experts representing countries across the globe including - Vietnam, Peru, Mexico, Iraq.
Shri @narendramodi will address the #CoWINGlobalConclave tomorrow, 5th July at 3 PM. https://t.co/Y7qZj7njVl
— PMO India (@PMOIndia) July 4, 2021
"The Conclave aims to share India's experience with regards to Universal Vaccination to fight Covid-19 through Co-WIN platform," as per the NHA website.
Considered as the "tech backbone" of India's inoculation drive, CoWin was developed in India as the central IT system for strategizing, implementing, monitoring, and evaluating Covid-19 vaccination across the country. Through CoWin, people can book a vaccination slot by registering with their mobile number. However, registration on this site is required to keep track of all vaccinations.
Further, people can download their vaccination certificates through the Cowin app. The Ministry of External Affairs expects that the Co-Win certificate will be recognized as genuine proof of immunisation by other countries.
About 50 countries, including Canada, Mexico, Nigeria, and Panama, want to use a system like CoWin for their vaccination drive. India has also agreed to share 'open-source software' for free. Dr. RS Sharma, chairman of the Empowered Group for the Covid-19 Vaccine Campaign, said late last month that Prime Minister Narendra Modi has directed officials to develop an open-source software of the software and provide it free of cost to any country interested in it.